These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2019913)

  • 1. [Experiment study on solubilization of cholesteatoma debris].
    Gyo K; Sasaki Y; Kobayashi T
    Nihon Jibiinkoka Gakkai Kaiho; 1991 Jan; 94(1):46-50. PubMed ID: 2019913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of keratin debris in conservative treatment of middle ear cholesteatoma: an in vitro study.
    Gyo K; Sasaki Y
    J Laryngol Otol; 1994 Feb; 108(2):113-5. PubMed ID: 7513006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human monocytes show chemotaxis in response to cholesteatoma debris].
    Iino Y; Toriyama M
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):25-31. PubMed ID: 1545307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and topological studies of cholesteatoma proteins, in relation to the keratinization process.
    Gillis E; Kluyskens P; Broeckaert D; Coucke P; Nsabumukunzi S; Reyniers P
    Acta Otorhinolaryngol Belg; 1980; 34(1):23-33. PubMed ID: 6162357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peritoneal macrophages with human cholesteatoma debris and alpha-keratin.
    Iino Y; Toriyama M; Ohmi S; Kanegasaki S
    Acta Otolaryngol; 1990; 109(5-6):444-9. PubMed ID: 1694387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha.
    Kurihara A; Toshima M; Yuasa R; Takasaka T
    Ann Otol Rhinol Laryngol; 1991 Dec; 100(12):989-98. PubMed ID: 1746847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-7 as a marker of cholesteatoma residue and its detection during surgery by an immunofluorescent method--a preliminary study.
    Takagi D; Hato N; Okada M; Hakuba N; Gyo K; Shigemoto K; Toda T; Ogasawara M; Kameda K
    Otol Neurotol; 2012 Apr; 33(3):396-9. PubMed ID: 22377647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol in cholesteatoma and in the otitis media syndrome.
    Sadé J; Teitz A
    Am J Otol; 1982 Jan; 3(3):203-8. PubMed ID: 7198868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical study of cholesteatoma and cholesterol granuloma--occurrence of delta 7-cholestenol in the tissues of cholesteatoma.
    Hayashida T; Iwamori M; Kitsuwa T; Nagai Y; Nomura Y
    ORL J Otorhinolaryngol Relat Spec; 1984; 46(5):242-7. PubMed ID: 6483382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteatoma and the middle ear cleft: a review of pathogenesis.
    Hughes GB
    Am J Otol; 1979 Oct; 1(2):109-14. PubMed ID: 554472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipoteichoic acid on proliferation and differentiation of keratinocytes.
    Yabe T; Huang CC
    Otolaryngol Head Neck Surg; 1989 Dec; 101(6):646-50. PubMed ID: 2574437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. A preliminary report.
    van Blitterswijk CA; Grote JJ
    Acta Otolaryngol; 1988; 105(5-6):529-32. PubMed ID: 2456666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteatoma debris as an activator of human monocytes. Potentiation of the production of tumor necrosis factor.
    Iino Y; Toriyama M; Ogawa H; Kawakami M
    Acta Otolaryngol; 1990; 110(5-6):410-5. PubMed ID: 1704675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilation tubes and cholesteatoma in children.
    Mortensen EH; Lildholdt T
    J Laryngol Otol; 1984 Jan; 98(1):27-9. PubMed ID: 6537964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
    Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
    Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratins in induced epidermoid formations and cholesteatoma lesions.
    Vennix PP; Kuijpers W; Tonnaer EL; Peters TA; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1990 May; 116(5):560-5. PubMed ID: 1691647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental middle ear cholesteatoma originated from free skin graft of the external ear].
    Hinohira Y
    Nihon Jibiinkoka Gakkai Kaiho; 1991 Jun; 94(6):794-804. PubMed ID: 1886032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of S100A1 in external auditory canal cholesteatoma.
    Naim R; Hormann K
    Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.